Abiopharma

News list

Director Watts Ryan J. 🔴 sold 35.2K shares of Denali Therapeutics Inc. (DNLI) at $16.50 Transaction Date: Jan 06, 2026 | Filing ID: 000004

Full text

News bot Jan. 8, 2026, 9:24 p.m.
🔍 Watts Ryan J. (Director)

Company: Denali Therapeutics Inc. (DNLI)

Report Date: 2026-01-06
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares sold: 35,198
- Total shares held: 2,152,604
Detailed Transactions and Holdings:
- Sold 35,198 shares of Common Stock at $16.5 per share (Direct)
  Date: 2026-01-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 296,833.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-06 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 2,152,604.00 | Footnotes: F3
Footnotes:
- F1: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs.
- F2: Includes 184,915 Unvested RSUs.
- F3: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.